Attitudes as a key factor for inclusion at university

[Abstract] Las actitudes pueden facilitar o dificultar el proceso inclusivo en la educación superior.Los objetivos del presente estudio son determinar las actitudes del alumnado y docentes hacia la discapacidad y conocer las variables que influyen en dichas actitudes. Se ha realizado un estudio descriptivo de prevalencia realizado en la Universidade da Coruña (UDC) con docentes (n= 121) y alumnos/as (n= 345) utilizando un cuestionario validado, autoadministrado y anonimizado (CUNIDIS). Se realizó un análisis descriptivo y un ANOVA para determinar las variables asociadas a las diferentes actitudes. Los resultados obtenidos manifiestan que los participantes creen preciso adaptar los materiales utilizados en las aulas, pero no los criterios de evaluación y cualificación. Sin embargo, indican que estas adaptaciones no se llevan a cabo realmente. La mayoría de los docentes indicaron que no están suficientemente formados para dar respuesta a las necesidades de los estudiantes con discapacidad. Se considera, por lo tanto, que los estudiantes y docentes de la UDC presentan, de manera general, unas actitudes favorables hacia la inclusión de los estudiantes con discapacidad[Abstract] Attitudes can facilitate or hinder the inclusive process in higher education. The aims of this study are exploring the attitudes of students and teachers towards disability and knowing which variables influence those attitudes. A descriptive prevalence study was carried out at the University of A Coruña (UDC) with teachers (n = 121) and students (n = 345) using a validated, self-administered and anonymous questionnaire (CUNIDIS). A descriptive analysis and an ANOVA were performed to determine the variables associated with the different attitudes. The results obtained show that the participants believe that it is necessary to adapt the materials used in the classrooms, but not the evaluation and qualification criteria. However, they indicate that these adaptations are not really carried out. Most teachers stated that they are not sufficiently trained to respond to the needs of students with disabilities. Therefore, it is considered that the students and teachers of the UDC present, in a general way, favorable attitudes towards the inclusion of students with disabilitie

Las actitudes como factor clave en la inclusión universitaria

Las actitudes pueden facilitar o dificultar el proceso inclusivo en la educación superior. Los objetivos del presente estudio son determinar las actitudes del alumnado y docentes hacia la discapacidad y conocer las variables que influyen en dichas actitudes. Se ha realizado un estudio descriptivo de prevalencia realizado en la Universidade da Coruña (UDC) con docentes (n= 121) y alumnos/as (n= 345) utilizando un cuestionario validado, autoadministrado y anonimizado (CUNIDIS). Se realizó un análisis descriptivo y un ANOVA para determinar las variables asociadas a las diferentes actitudes. Los resultados obtenidos manifiestan que los participantes creen preciso adaptar los materiales utilizados en las aulas, pero no los criterios de evaluación y cualificación. Sin embargo, indican que estas adaptaciones no se llevan a cabo realmente. La mayoría de los docentes indicaron que no están suficientemente formados para dar respuesta a las necesidades de los estudiantes con discapacidad. Se considera, por lo tanto, que los estudiantes y docentes de la UDC presentan, de manera general, unas actitudes favorables hacia la inclusión de los estudiantes con discapacidad

Assessment of platelet REACtivity after transcatheter aortic valve replacement

OBJECTIVES: The REAC-TAVI (Assessment of platelet REACtivity after Transcatheter Aortic Valve Implantation) trial enrolled patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) pre-treated with aspirin + clopidogrel, aimed to compare the efficacy of clopidogrel and ticagrelor in suppressing high platelet reactivity (HPR) after TAVI. BACKGROUND: Current recommendations support short-term use of aspirin + clopidogrel for patients with severe AS undergoing TAVR despite the lack of compelling evidence. METHODS: This was a prospective, randomized, multicenter investigation. Platelet reactivity was measured at 6 different time points with the VerifyNow assay (Accriva Diagnostics, San Diego, California). HPR was defined as (P2Y12 reaction units (PRU) ≥208. Patients with HPR before TAVR were randomized to either aspirin + ticagrelor or aspirin + clopidogrel for 3 months. Patients without HPR continued with aspirin + clopidogrel (registry cohort). The primary endpoint was non-HPR status (PRU <208) in ≥70% of patients treated with ticagrelor at 90 days post-TAVR. RESULTS: A total of 68 patients were included. Of these, 48 (71%) had HPR (PRU 273 ± 09) and were randomized to aspirin + ticagrelor (n = 24, PRU 277 ± 08) or continued with aspirin + clopidogrel (n = 24, PRU 269 ± 49). The remaining 20 patients (29%) without HPR (PRU 133 ± 12) were included in the registry. Overall, platelet reactivity across all the study time points after TAVR was lower in patients randomized to ticagrelor compared with those treated with clopidogrel, including those enrolled in the registry (p < 0.001). The primary endpoint was achieved in 100% of patients with ticagrelor compared with 21% with clopidogrel (p < 0.001). Interestingly, 33% of clopidogrel responder patients at baseline developed HPR status during the first month after TAVR. CONCLUSIONS: HPR to clopidogrel is present in a considerable number of patients with AS undergoing TAVR. Ticagrelor achieves a better and faster effect, providing sustained suppression of HPR to these patients. (Platelet Reactivity After TAVI: A Multicenter Pilot Study [REAC-TAVI]; NCT02224066)

Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial

OBJECTIVES: The REAC-TAVI (Assessment of platelet REACtivity after Transcatheter Aortic Valve Implantation) trial enrolled patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) pre-treated with aspirin + clopidogrel, aimed to compare the efficacy of clopidogrel and ticagrelor in suppressing high platelet reactivity (HPR) after TAVI. BACKGROUND: Current recommendations support short-term use of aspirin + clopidogrel for patients with severe AS undergoing TAVR despite the lack of compelling evidence. METHODS: This was a prospective, randomized, multicenter investigation. Platelet reactivity was measured at 6 different time points with the VerifyNow assay (Accriva Diagnostics, San Diego, California). HPR was defined as (P2Y12 reaction units (PRU) ≥208. Patients with HPR before TAVR were randomized to either aspirin + ticagrelor or aspirin + clopidogrel for 3 months. Patients without HPR continued with aspirin + clopidogrel (registry cohort). The primary endpoint was non-HPR status (PRU <208) in ≥70% of patients treated with ticagrelor at 90 days post-TAVR. RESULTS: A total of 68 patients were included. Of these, 48 (71%) had HPR (PRU 273 ± 09) and were randomized to aspirin + ticagrelor (n = 24, PRU 277 ± 08) or continued with aspirin + clopidogrel (n = 24, PRU 269 ± 49). The remaining 20 patients (29%) without HPR (PRU 133 ± 12) were included in the registry. Overall, platelet reactivity across all the study time points after TAVR was lower in patients randomized to ticagrelor compared with those treated with clopidogrel, including those enrolled in the registry (p < 0.001). The primary endpoint was achieved in 100% of patients with ticagrelor compared with 21% with clopidogrel (p < 0.001). Interestingly, 33% of clopidogrel responder patients at baseline developed HPR status during the first month after TAVR. CONCLUSIONS: HPR to clopidogrel is present in a considerable number of patients with AS undergoing TAVR. Ticagrelor achieves a better and faster effect, providing sustained suppression of HPR to these patients. (Platelet Reactivity After TAVI: A Multicenter Pilot Study [REAC-TAVI]; NCT02224066)

Las actitudes como factor clave en la inclusión universitaria

Las actitudes pueden facilitar o dificultar el proceso inclusivo en la educación superior. Los objetivos del presente estudio son determinar las actitudes del alumnado y docentes hacia la discapacidad y conocer las variables que influyen en dichas actitudes. Se ha realizado un estudio descriptivo de prevalencia realizado en la Universidade da Coruña (UDC) con docentes (n= 121) y alumnos/as (n= 345) utilizando un cuestionario validado, autoadministrado y anonimizado (CUNIDIS). Se realizó un análisis descriptivo y un ANOVA para determinar las variables asociadas a las diferentes actitudes. Los resultados obtenidos manifiestan que los participantes creen preciso adaptar los materiales utilizados en las aulas, pero no los criterios de evaluación y cualificación. Sin embargo, indican que estas adaptaciones no se llevan a cabo realmente. La mayoría de los docentes indicaron que no están suficientemente formados para dar respuesta a las necesidades de los estudiantes con discapacidad. Se considera, por lo tanto, que los estudiantes y docentes de la UDC presentan, de manera general, unas actitudes favorables hacia la inclusión de los estudiantes con discapacidad

Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.

The REAC-TAVI (Assessment of platelet REACtivity after Transcatheter Aortic Valve Implantation) trial enrolled patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) pre-treated with aspirin + clopidogrel, aimed to compare the efficacy of clopidogrel and ticagrelor in suppressing high platelet reactivity (HPR) after TAVI. Current recommendations support short-term use of aspirin + clopidogrel for patients with severe AS undergoing TAVR despite the lack of compelling evidence. This was a prospective, randomized, multicenter investigation. Platelet reactivity was measured at 6 different time points with the VerifyNow assay (Accriva Diagnostics, San Diego, California). HPR was defined as (P2Y12 reaction units (PRU) ≥208. Patients with HPR before TAVR were randomized to either aspirin + ticagrelor or aspirin + clopidogrel for 3 months. Patients without HPR continued with aspirin + clopidogrel (registry cohort). The primary endpoint was non-HPR status (PRU  A total of 68 patients were included. Of these, 48 (71%) had HPR (PRU 273 ± 09) and were randomized to aspirin + ticagrelor (n = 24, PRU 277 ± 08) or continued with aspirin + clopidogrel (n = 24, PRU 269 ± 49). The remaining 20 patients (29%) without HPR (PRU 133 ± 12) were included in the registry. Overall, platelet reactivity across all the study time points after TAVR was lower in patients randomized to ticagrelor compared with those treated with clopidogrel, including those enrolled in the registry (p  HPR to clopidogrel is present in a considerable number of patients with AS undergoing TAVR. Ticagrelor achieves a better and faster effect, providing sustained suppression of HPR to these patients. (Platelet Reactivity After TAVI: A Multicenter Pilot Study [REAC-TAVI]; NCT02224066)

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation A Report From the GARFIELD-AF Registry

IMPORTANCE Congestive heart failure (CHF) is commonly associated with nonvalvular atrial fibrillation (AF), and their combination may affect treatment strategies and outcomes